| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ELP3_0000800 | Exon-Exon | chr8:27957345-27970690 | chr8:28099828-28113173 | 429 nt | 0.4476 |
| hsa_ELP3_0000900 | Intron-Exon-Intron | chr8:27957345-27971339 | chr8:28099828-28113822 | 64 nt | 0.4688 |
| hsa_ELP3_0000500 | Exon-Exon | chr8:27957345-27989921 | chr8:28099828-28132404 | 787 nt | 0.4574 |
| hsa_ELP3_0000600 | Exon-Exon | chr8:27957345-27995408 | chr8:28099828-28137891 | 981 nt | 0.4669 |
| hsa_ELP3_0001000 | Exon-Exon | chr8:27957345-28019595 | chr8:28099828-28162078 | 343 nt | 0.4956 |
| hsa_ELP3_0001100 | Exon-Exon | chr8:27957451-27967955 | chr8:28099934-28110438 | 237 nt | 0.4684 |
| hsa_ELP3_0001200 | Intron-Exon-Intron | chr8:27964204-27970690 | chr8:28106687-28113173 | 97 nt | 0.3711 |
| hsa_ELP3_0001800 | Exon-Exon | chr8:27964230-28019595 | chr8:28106713-28162078 | 82 nt | 0.4634 |
| hsa_ELP3_0002100 | Exon-Exon | chr8:27965430-27989921 | chr8:28107913-28132404 | 260 nt | 0.4885 |
| hsa_ELP3_0002200 | Intron-Intron | chr8:27966166-27966693 | chr8:28108649-28109176 | 528 nt | 0.4489 |
A study in human bladder cancer demonstrated that the circELP3 contributes to cancer progression and cisplatin resistance [Huang et al. DOI:10.3390/cells11091381].